An extensive overview on precision medicine by Paolo Tarantino and Sara Tolaney
Florez Lab shared a post on X:
”Dr. Paolo Tarantino and Dr. Sara Tolaney are moderating together giving us an extensive overview on precision medicine and its role in early to metastatic breast cancer.”
Paolo Tarantino shared a post by Florez Lab on X, adding:
”So many evolutions in the treatment of metastatic breast cancer over the last few years.
A honor to have the chance to review them with my mentor Sara Tolaney.
Thanks Narjust Florez for having us and for putting together this terrific precision medicine conference!”
Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023